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O B J E C T I V E S We sought to determine the gender-speciﬁc effects of obesity on myocardial
metabolism, work, and efﬁciency.
B A C KG ROUND Myocardial metabolism abnormalities may contribute to the development of
obesity-related heart failure. Increased myocardial oxygen consumption (MVO2) and fatty acid (FA)
metabolism and decreased efﬁciency occur with obesity in women. It is unknown whether similar
changes occur with obesity in men.
METHOD S We quantiﬁed cardiac work, efﬁciency, myocardial blood ﬂow (MBF), MVO2, glucose, and
FA metabolism with echocardiography and positron emission tomography in nonobese and obese men
and women (N  86).
R E S U L T S There were signiﬁcant differences between the obese (n  35) and nonobese (n  51)
subjects in age, body composition, plasma lipids, and insulin resistance in addition to differences
between the men (n  30) and women (n  56) in body composition and plasma lipids. Female gender
independently predicted increased cardiac work (p  0.001). Female gender also related to lower
efﬁciency (p  0.05). Obesity and female gender independently predicted greater MBF (p  0.01, p 
0.0005, respectively) and MVO2 (p  0.0005, p  0.0001). Myocardial glucose uptake was not different
among the 4 subject groups, but obesity and gender interacted in predicting glucose uptake (p  0.05).
Lower myocardial glucose utilization was independently predicted by female gender (p  0.05), and it
independently predicted lower myocardial glucose utilization/plasma insulin (p  0.05). Obesity and
gender signiﬁcantly interacted in the determination of glucose utilization/plasma insulin (p  0.01).
There were no differences in FA uptake among the 4 groups, and although increasing obesity correlated
with greater myocardial FA utilization and oxidation; female gender (p  0.005, p  0.01) and plasma
triglycerides (p  0.05, p  0.005) were their independent predictors.
CONC L U S I O N S Women’s and men’s myocardial metabolic responses to obesity are not exactly the
same. Obesity and gender modulate MBF and MVO2, are related to myocardial substrate metabolism, and
sometimes interact in its prediction. Gender modiﬁes efﬁciency. Gender-related differences in myocardial
metabolism may affect the development of/adaptation to obesity-related cardiac disease. (J Am Coll
Cardiol Img 2008;1:424–33) © 2008 by the American College of Cardiology Foundation
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425besity is an independent risk factor for
heart failure and is thought to contribute
to 11% of heart failure cases among men
and 14% among women, which are alarm-
ng percentages given the recent increase in obesity
revalence (1). The etiology of obesity-associated
eart failure is not completely understood. There is
n increase in plasma volume, neurohormonal acti-
ation, and hemodynamic load (2). However, there
re also intrinsic changes to the human myocardium
hat are independent of load (3).
See page 434
One of these changes appears to be an alteration in
yocardial metabolism. Because of the inherent link
etween myocardial substrate metabolism for genera-
ion of energy and cardiac function and because
ncreased myocardial fatty acid (FA) metabolism
nd/or storage detrimentally affects cardiac function in
nimal models of obesity, we recently investigated
besity’s effects on myocardial metabolism in young
omen (4,5). We showed that myocardial oxygen
onsumption (MVO2) directly correlated with in-
reased body mass index (BMI). In addition, we
emonstrated that increases in myocardial FA utiliza-
ion and oxidation were predicted by increasing insu-
in resistance in these women (5).
There are no data, however, comparing the
ffects of obesity on myocardial metabolism in men
nd women. Epidemiologic data have been used by
uthors to suggest gender-related differences in the
eart’s response to obesity (1). Also, the results of
tudies performed only in men with impaired glu-
ose tolerance and control patients do not show the
ame myocardial FA metabolism changes found in
ur study of women (6,7). Furthermore, gender
ffects total body, muscle, hepatic, and myocardial
ubstrate metabolism in nonobese subjects (8–10).
hus, the purpose of this study was to determine
hether myocardial metabolic remodeling in re-
ponse to obesity differs between men and women.
E T H O D S
tudy subjects. In this prospective study, we evaluated
oung men and premenopausal women. Of the men,
1 were obese (BMI 30 kg/m2) and 19 were
onobese (BMI 30 kg/m2); of the women, 24 were
bese and 32 were nonobese. None of the data were in
ur first study of obesity in women. All subjects
nderwent a screening medical history, physical ex-
mination, and phlebotomy for fasting routine chem-
stries and lipid panels. Obese subjects underwent 2-h mlucose tolerance tests. Subjects were excluded if they
ere 350 pounds, diabetic, hypertensive, smokers,
onsedentary, taking vasoactive or lipid medications,
r if they had cardiac disease (per history, physical
xamination, echocardiograms and, if indicated, rest/
tress echocardiograms). The Institutional Review
oard at the Washington University School of Med-
cine approved this study. All subjects signed informed
onsent.
xperimental procedure. Subjects underwent dual-
nergy X-ray absorptiometry (QDR-1000/w; Ho-
ogic, Bedford, Massachusetts) for body composition
easurements. All positron emission tomography
PET) studies were performed on an ECAT 962
R (Siemens Medical Systems, Iselin, New Jersey)
t 8:00 AM to avoid circadian variations in patients.
ubjects were admitted to the General Clinical Re-
earch Center at Washington University; they were
iven a standardized meal the night before the PET
tudy, and then they fasted for 12 h before PET
maging. Subjects were on telemetry and had
heir blood pressure measurements taken
hroughout the study.
ositron emission tomography measure-
ents of myocardial blood ﬂow (MBF) and
etabolism. Subjects underwent placement
nd transmission scans (for attenuation cor-
ection). Positron emission tomography im-
ging was performed after the injection of
5O-water, 11C-acetate, 1-11C-glucose, and
-11C-palmitate (10–14). Throughout the
ET study, we obtained plasma substrates,
nsulin, and radiolabeled metabolites, which
re required for compartmental modeling of
he PET data (13,14). Blood and myocardial time-
ctivity curves were used in conjunction with well-
stablished kinetic models to quantify MBF, MVO2,
lucose extraction fraction, and FA extraction fraction
which was further divided into the portions that
ntered oxidation and slow turnover pools) in patients
15). These extraction fractions were then used in
onjunction with MBF and plasma substrate levels to
alculate uptake and utilization of glucose and FA and
A oxidation (10,15).
lasma analyses and whole-body insulin resistance.
lasma insulin and glucose were measured with the
tilization of radioimmunoassay (Millipore, Bil-
erica, Massachusetts) and using a Cobas Mira
nalyzer (Roche Diagnostics, Basel, Switzerland),
espectively. Free FAs and lactate in the plasma
ere measured with an enzymatic colorimetric
ethod (NEFA C kit, WAKO Chemicals, Rich-
A B B
A N D
BMI
FA
HOMA
assess
LV
MBF
MVO2
consu
PET
tomogond, Virginia) and photospectrometry (R E V I A T I O N S
A C R O N YM S
bodymass index
fatty acid
 homeostasis model
ment of insulin resistance
left ventricular
myocardial blood flow
myocardial oxygen
mption
positron emissionSigma
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426hemical Co., St. Louis, Missouri). Insulin resis-
ance was calculated with the homeostasis model
ssessment (HOMA)  (fasting insulin [U/ml] ·
asting glucose [mmol/l]/22.5).
chocardiography. Immediately after MVO2 mea-
urement, subjects underwent a 2-dimensional and
oppler echocardiographic examination for quan-
ification of left ventricular (LV) size and function
sing a Sequoia-C256 (Acuson-Siemens, Moun-
ain View, California) or a Vivid 7 (GE Medical
ystems, Horten, Norway). Left ventricular mass
as determined with the area-length method. Left
entricular ejection fraction was calculated with
tilization of the modified Simpson’s method. Car-
iac work and efficiency were calculated as previ-
usly described (5,10).
tatistical analysis. We used SAS software (SAS
nstitute, version 9, Cary, North Carolina) for the
nalyses. Data are listed as mean value  SD.
kewed variables (plasma triglycerides and myocar-
ial glucose utilization/plasma insulin) were log
ransformed. Data comparisons between any 2 of
he 4 subject sets were made with unadjusted
airwise comparisons. Analyses involving both obe-
ity status and gender were performed with a
-factor analysis of variance. Outcome variables
ere MBF, MVO2, myocardial glucose uptake,
tilization, utilization/plasma insulin, myocardial
A uptake, utilization, and oxidation, cardiac work,
nd efficiency. In our initial analyses, we evaluated
nteractions between obesity and gender. When the
nteraction was not significant, we evaluated main
ffects to assess the significance of the individual
Table 1. Subjects’ Clinical Characteristics
Nonobese
Men Women
n 19 32
Age (yrs) 26 6 27 6
Race, % white 79 50
Weight, kg 79 8 63 8
Body mass index, kg/m2 24 3 24 3
Fat-free mass, kg 64 6 44 4
Fat mass, kg 14 6 19 6
Fat, % 18 6 30 6
Waist circumference, cm 82 5 78 10
Total cholesterol, mg/dl 158 27 157 27
LDL, mg/dl 91 23 81 23
HDL, mg/dl 49 11 62 13
Triglycerides, mg/dl 88 33 67 22
HOMA 0.86 0.38 1.09 0.64HDL  high-density lipoprotein; HOMA  homeostasis model assessment of insulinactors. In one instance, there was a significant
besity by gender interaction that reflected a greater
ecrease in myocardial glucose utilization/plasma
nsulin in men than in women. Because the direc-
ion of the effect was the same in both genders, we
lso report a gender effect in a 2-factor analysis of
ariance that does not include an interaction term.
To evaluate the independent effect of potential
ovariates (age, mean arterial pressure, HOMA,
nd plasma triglycerides) that were associated with
utcome measures (p  0.10) and to evaluate the
ovariate-adjusted significance of gender and obesity,
e included these variables in a stepwise analysis of
ovariance that produced a best set of predictors. In
hese multivariate models, each independent variable
as adjusted for all other independent variables. The
elationship between plasma FAs and myocardial FA
tilization or oxidation was not analyzed because
lasma FAs are used in their calculation. Similarly,
OMA and myocardial glucose utilization/plasma
nsulin’s relationship was not analyzed. A p  0.05
as considered significant.
E S U L T S
linical characteristics and LV structure/function. The
onobese and obese differed in almost all clinical
haracteristics (Table 1). The genders differed in
ody composition, high-density lipoprotein, and
riglyceride levels (Table 1). There were racial
ifferences between the men and women (p 0.05)
ut no racial differences in any of the outcomes
data not shown).
Obese p Value
Men Women
Obese vs.
Nonobese
Men vs.
Women
11 24
5 5 36 9 0.0001 NS
100 71 0.09 0.05
8 11 113 19 0.0001 0.14
7 2 42 7 0.0001 0.17
8 7 56 8 0.0001 0.0001
8 6 48 10 0.0001 0.05
2 4 46 4 0.0001 0.0001
0 9 117 16.5 0.0001 0.17
0 35 174 40 0.01 0.45
8 29 97 29 0.01 0.13
8 7 52 11 0.0005 0.0001
7 118 128 71 0.0001 0.005
3 1.90 2.52 1.09 0.0001 0.53
11
3
7
3
3
12
19
10
3
24
3.8resistance; LDL  low-density lipoprotein.
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427The obese had higher blood pressure, heart rate,
ate-pressure product, and LV mass than the non-
bese (Table 2). The men had greater LV mass and
ower LV mass/fat-free mass, ejection fraction, and
ardiac work compared with the women (Table 2).
emale gender related to greater work (Table 3 lists
ll univariate relationships) and was its only inde-
endent predictor (Table 3 lists all multivariate
odel results).
Table 2. Hemodynamics and LV Structure and Function
Non
Men
Hemodynamics
Systolic blood pressure, mm Hg 114 17
Diastolic blood pressure, mm Hg 63 9
Mean arterial pressure, mm Hg 81 10
Heart rate, beats/min 56 6
Rate-pressure product, mm Hg · beats/min 6,507 1,157
LV structure
LV mass, g 175 38
LV mass/fat-free mass (g/kg) 2.73 0.42
LV systolic function
Ejection fraction, % 59 5
Cardiac work (j/g/min) 0.24 0.07
LV efﬁciency (%) 13.8 2.6
LV  left ventricular.
Table 3. MBF  Myocardial Substrate Uptake and Metabolism:
MBF MVO2
Glucose
Uptake
G
Ut
Univariate analyses results
Obesity 0.005 0.0001 NS
Gender 0.0001 0.0001 NS
Plasma triglyceride NS NS NS
Age NS NS NS
Mean arterial pressure NS NS NS
Multivariate analyses results
Obesity 0.01 0.0005 NS
Gender 0.0005 0.0001 NS
Plasma triglyceride NS NS NS
Age NS NS NS
Mean arterial pressure NS NS NS
Signiﬁcance of interactions
between obesity and
gender on outcomes
p Values 0.15 0.11 0.05FA  fatty acid; MBF  myocardial blood ﬂow; MVO2  myocardial oxygen consumlasma substrate and insulin levels. Table 4 shows
evels during the PET study. Glucose levels were
reater in the obese and in men; lactate was greater
n men; insulin was greater in the obese.
yocardial blood ﬂow, MVO2, and efﬁciency. Figure
A depicts MBF (nonobese men, 0.95  0.19 ml ·
1 · min1; obese men 0.99  0.18 ml · g1 ·
in1; nonobese women 1.10  0.21 ml · g1 ·
in1; and obese women, 1.29  0.30 ml · g1 ·
se Obese
Women Men Women
Obes
Nono
111 12 133 11 127 14 0.0
69 8 73 8 71 6 0.0
83 6 93 9 89 7 0.0
62 10 71 10 70 11 0.0
6,954 1,289 9,395 1,801 8,798 1,630 0.0
121 20 209 29 173 29 0.0
2.74 0.39 2.71 0.43 3.02 0.68 0.2
62 5 59 6 62 5 0.9
0.34 0.09 0.29 0.04 0.38 0.11 0.0
13.1 3.6 15.1 3.6 12.3 4.9 0.6
ariate, Multivariate, and Interaction Analyses
ose
tion
Glucose
Utilization, Insulin
FA
Uptake
FA
Utilization
FA
Oxidation
S 0.0005 NS 0.01 0.001
05 NS .05 .05 0.05
S r  0.43;
p  0.0001
NS r  0.31;
p  0.01
r  0.39;
p  0.001
S NS NS r  0.24;
p  0.06
r  0.29;
p  0.05
r
p
S NS NS r  0.25;
p  0.05
r  0.31;
p  0.01
S NS NS NS NS
05 0.05 0.05 0.005 0.01
S 0.01 NS 0.05 0.005
S NS NS NS NS
S NS NS NS NS
1 0.01 0.75 0.6 0.78obe p Value
e vs.
bese
Men vs.
Women
001 0.44
05 0.16
01 0.88
001 0.12
001 0.73
001 0.0001
1 0.0001
9 0.005
8 0.0001
2 0.05Univ
luc
iliza
Cardiac
Work Efﬁciency
N 0.06 NS
0. 0.001 0.05
N NS r  0.21;
p  0.05
N  0.21;
 0.06
NS
N NS NS
N NS NS
0. 0.001 NS
N NS 0.05
N NS NS
N NS NS
0.1 0.69 0.47ption; NS  not signiﬁcant.
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428in1). Figure 1B shows MVO2 (nonobese men,
.1  0.8 ml · g1 · min1; obese men, 4.5  1.3
l · g1 · min1; nonobese women, 5.8  1.0 ml ·
1 · min1; obese women, 7.1  1.6 ml · g1 ·
in1). The effects of gender and obesity on MBF
nd MVO2 also are demonstrated in Figures 2, 3,
nd 4. Female gender and obesity independently
redicted MBF and MVO2, accounting for 22%
nd 47% of their variability, respectively. Obesity
nd gender did not interact in determining MBF or
VO2 (Table 3 lists all interaction results).
Women had lower efficiency than men (Table 2),
nd female gender independently predicted lower
fficiency (p 0.05). However, if plasma triglycerides
ere added to the multivariate model, gender lost its
ignificance, likely because of the relationship between
ender and triglycerides (p  0.005).
= Nonobese men = Obese men
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
M
B
F 
(m
L•
g-
1 •
m
in
-
1 )
p<0.005
p<0.05
p<0.01p=NS
A
Figure 1. MBF and MVO2 in obese and nonobese men and wom
Panel A shows MBF, which we quantiﬁed using positron emission t
comparisons are shown. The obese women had the greatest MBF, w
obese men. The nonobese women also had greater resting MBF tha
determined with the utilization of positron emission tomography. O
than the nonobese women and the obese men. Nonobese women
Table 4. Plasma Substrate and Insulin Levels During the Positro
Nonobese
Men Women
Free fatty acids, nmol/ml 516 214 656 325
Glucose, mol/ml 4.93 0.29 4.81 0.40
Lactate, nmol/ml 745 280 659 170
Insulin, U/ml 3.94 1.66 4.99 2.52blood ﬂow; MVO2  oxygen consumption.In exploratory analyses, we evaluated the effect of
ardiac work on MVO2. Work related in a univar-
ate manner to MVO2 (r 0.36, p 0.001) but did
ot independently predict it, likely because of the
ignificant relationship between gender and work.
lso, given gender differences in LV mass/fat-free
ass, we determined that it significantly interacted
ith gender in the prediction of MBF, and when
dded to the model, obesity was no longer an
ndependent predictor. In this model, LV mass/fat-
ree mass and gender accounted for 32% of the
ariation in MBF.
yocardial glucose uptake, utilization, and utilization/
lasma insulin. Myocardial glucose uptake was not
ifferent among the groups, and although gender
nd obesity were not significantly related to uptake,
hey significantly interacted in predicting uptake
= Nonobese women = Obese women
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graphy, in the 4 subject groups. The p values for the pairwise
h was signiﬁcantly greater than in the nonobese women or the
e nonobese men. Panel B shows MVO2 levels in the groups, as
e women had the greatest MVO2, which was signiﬁcantly greater
had greater MVO2 than the nonobese men. MBF  myocardial
mission Tomography Study
Obese p Value
Men Women
Obese vs.
Nonobese
Men vs.
Women
1 178 705 199 0.09 0.08
5 0.47 5.06 0.49 0.005 0.05
7 423 576 252 0.67 0.05
6 8.16 11.4 4.6 0.0001 0.63en
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429Fig. 5A, Table 3). Myocardial glucose utilization
as not different among the subjects, but female
ender predicted lower glucose utilization (p 
.05). Figure 5B shows myocardial glucose utiliza-
ion/plasma insulin (nonobese men, 90  64 [nmol
g1 · min1]/[U · ml1]; obese men, 17  23
nmol · g1 · min1]/[U · ml1]; nonobese women,
5 43 [nmol · g1 · min1]/[U · ml1]; and obese
omen, 25  25 [nmol · g1 · min1]/[U · ml1].
t related inversely to obesity and plasma triglycerides,
ut not gender. However, in the multivariate analysis,
M
B
F 
(m
L•
g-
1 •
m
in
-
1 )
BMI (kg/m2)
p=NS
Men
0
0.5
1
1.5
2
2.5
0 10 20 30 40 50
Figure 2. MBF Versus BMI in Men and Women
This ﬁgure demonstrates the relationships between MBF, quantiﬁed
women. The correlations between BMI and MBF were only signiﬁca
MBF in men and women were not statistically different. BMI  bod
M
VO
2 
(µm
ol•
g-
1 •
m
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-
1 )
BMI
(kg•[m2]-1)
p=NS
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6
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10
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Figure 3. MVO2 Versus BMI in Men and Women
These graphs show how MVO2, quantiﬁed using positron emission
relation between MVO2 and BMI was only signiﬁcant in the women
statistically different. BMI  body mass index; MVO2  oxygen consumemale gender (p  0.05) and plasma triglycerides (p
0.01) predicted lower myocardial glucose utiliza-
ion/insulin, accounting for 32% of its variability.
besity and gender interacted in predicting myocar-
ial glucose utilization/insulin (Fig. 5B, Table 3).
yocardial FA uptake, utilization, and oxidation.
here were no differences in myocardial FA uptake
mong the 4 groups (Figs. 6A to 6C). However,
emale gender predicted increased FA uptake (p 
.05). Myocardial FA utilization (nonobese men,
11 48 nmol · g1 · min1; obese men, 149 41
BMI (kg/m2)
r=0.30
p=0.03
Women
0
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1
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2
.5
0 20 40 60
ng positron emission tomography, and BMI in men and in
the women. However, r values for the correlations of BMI with
ass index; MBF  myocardial blood ﬂow.
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430mol · g1 · min1; nonobese women, 142  50
mol · g1 · min1; and obese women, 169  40
mol · g1 · min1), related to obesity, female
ender, age, plasma triglyceride levels, and mean
rterial pressure (Table 3). However, only female
ender and triglyceride levels independently pre-
icted increased FA utilization, accounting for 27%
f its variability. Myocardial FA oxidation (non-
bese men, 101  44 nmol · g1 · min1; obese
en, 140  41 nmol · g1 · min1; nonobese
omen, 122  43 nmol · g1 · min1; and obese
omen, 156  40 nmol · g1 · min1) related to
besity, female gender, age, plasma triglycerides,
nd mean arterial pressure, but only plasma triglyc-
rides and gender independently predicted it, ac-
ounting for 31% of its variability.
I S C U S S I O N
ur results are the first to demonstrate different
yocardial metabolic signatures in men and women
Figure 4. Typical PET Images and Time-Activity Curves
Top left, typical positron emission tomography (PET)-derived, horizo
our study after injection with 1-11C-acetate. Compared with the non
women’s myocardium shows greater tracer accumulation in the my
the woman’s myocardium, corresponding to greater tracer uptake).
curves (solid lines) from the corresponding PET images, which weren response to obesity. Specifically, both obesity and memale gender independently predict greater MBF
nd MVO2. Female gender independently predicts
reater cardiac work, lower myocardial glucose uptake,
tilization, and utilization/plasma insulin. Moreover,
besity and gender interact in determining myocardial
lucose uptake and insulin sensitivity, which high-
ights the complexity of their relationship on influenc-
ng myocardial metabolism. Although obesity and
yocardial FA metabolism correlate, female gender
ndependently predicts greater FA metabolism, and
emale gender relates to inefficiency. (Of note, multi-
ariate analyses with utilization of the continuous
ariable, BMI, instead of obese/nonobese, did not
lter any of our results; data not shown.)
Our finding that both obesity and gender affect
BF helps explain the apparently conflicting re-
ults of studies regarding obesity and MBF. In our
tudy of women, obesity predicted MBF but, in
nother study of men, obesity did not (5,16). The
nteraction between gender and LV mass/fat-free
l long-axis image from the myocardium of a nonobese man in
se man, the PET-derived image after 1-11C-acetate from an obese
dium (more white and red graphically indicate greater counts in
tom panels, blood (dashed lines) and myocardial time-activity
ed in conjunction with compartmental models to quantify MVO2.nta
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431besity likely involve a complex interaction between
asodilatory and constrictive influences, including
ex hormones, genomic differences, hormone recep-
ors, and metabolites, as evidenced by the fact that
en and women’s vasoactive responses to sex hor-
ones are not the same (17,18).
The increase in MVO2 with obesity and female
ender extends our previous findings that demon-
trated increasing MVO2 with increasing obesity in
omen (5). Cardiac work influences MVO2 but
as not an independent predictor. (The significant
elationship of work with female gender further
nderscores the complexity of the influences on
VO2.) The increased MVO2 observed in women
nd the obese may be in part the result of increased
yocardial FA oxidation related to female gender
nd obesity because FA oxidation is less oxygen
fficient than glucose oxidation. The borderline
igher plasma FA levels in the obese and in the
omen may also increase MVO2 via up-regulation
f uncoupling proteins; greater estrogen levels in
omen may also increase MVO2 via up-regulation
f uncoupling proteins and their function (19,20).
p-regulation of uncoupling proteins uncouples
xygen consumption from adenosine triphosphate
roduction (for cardiac work), hence, they may also
lay a role in the lower efficiency observed in
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Figure 5. Myocardial Glucose Uptake and Glucose Utilization/Pl
Panels A and B show the groups’ myocardial glucose uptake and gluc
were measured with positron emission tomography and insulin with a
prediction of glucose uptake (p  0.05) is shown graphically because
glucose uptake differ in men and women. Obese men have lower upt
than nonobese women. Obesity and gender also interacted in determ
nitude of the difference between the obese and nonobese men and tomen. rConcordant with our previous results in women,
besity at first glance appears to have little effect on
lucose metabolism (5). However, with obesity, and
ncreasing whole-body insulin resistance, the myo-
ardium utilizations less glucose/plasma insulin and
hus appears insulin resistant. Furthermore, obesity
nd gender interact significantly in the prediction of
lucose uptake and glucose utilization/insulin, and
emale gender is an independent predictor of lower
lucose utilization/plasma insulin. Female gender
lso predicts less myocardial glucose utilization.
strogen may be involved in this lower glucose
ptake and utilization because it decreases glucose
xidation, gluconeogenesis, and glycogenolysis in
ther organs and reduces glucose transporter 4
ranslocation to the cell surface, thereby inhibiting
lucose uptake (21–23). Female gender also may
ecrease glucose metabolism via the Randle cycle as
he result of women’s greater whole-body FA turn-
ver, delivery to the myocardium, and myocardial
A oxidation (22).
Our results also clarify apparently conflicting
esults from previous myocardial FA metabolism
tudies in obese humans: those in women demon-
trated increased FA metabolism, whereas those in
en did not (5,6,24). Our current study demon-
trates that although both obesity and gender are
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432tronger predictor and therefore must be taken into
ccount when determining obesity’s effect. The
elationship between plasma triglycerides and obe-
ity may also have caused the relationship between
besity and the measures of FA metabolism to be
ess significant in multivariate models. The increase
n myocardial FA metabolism found in patients
ith obesity is likely secondary to increased presen-
ation of plasma FA to the myocardium, resulting
rom obesity’s known increase in whole-body FA
urnover. Additionally, estrogen increases lipopro-
ein lipase’s and FA oxidation enzymes’ activity and
o may partly explain the increase in myocardial FA
etabolism in women (25,26).
tudy limitations. Our findings may not apply to
ubjects who do not fit our entry criteria. This study
as not powered to evaluate the effect of sex hormones
nd menstrual phase on myocardial metabolism but
ather to evaluate the effects of gender and obesity and
heir interactions. Further studies are needed to de-
ermine whether these variables are involved in the
echanism(s) that influence gender-related myocar-
ial metabolic adaptations to obesity. We did not
valuate the metabolism of endogenous substrates or
ther exogenous substrates (e.g., lactate), although
hey would be expected to contribute little to myocar-
ial metabolism in the rested state.
linical implications. Given the link between metab-
lism and function, changes in myocardial metabolism
ue to obesity may contribute to obesity-related con-
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Figure 6. Myocardial FA Uptake and Metabolism
Shown is a depiction of the groups’ myocardial fatty acid (FA) upta
positron emission tomography. Pairwise comparisons show no diffe
in the obese men compared with nonobese men. Fatty acid oxidat
it was greater in the obese women compared with nonobese womractile dysfunction. Increased MVO2 in obesity may contribute to decreased function via impaired effi-
iency of transformation of chemical energy into
echanical function. Increased FA oxidation with
besity may also lead to LV dysfunction, as observed
n animal models (27). Further studies are necessary to
rove that altered myocardial metabolism (accounting
or gender-related differences) contributes to the de-
elopment of obesity-related cardiac dysfunction.
Myocardial insulin resistance in obesity likely
ffects the myocardium’s ability to adapt to chang-
ng conditions. One would speculate that insulin-
esistant myocardium would not be able to adapt to
schemia (which requires glucose use) as well as the
nsulin-sensitive heart. Further investigation in
schemic myocardium is needed.
Our finding of gender-related differences in the
yocardial metabolic response to obesity makes it
empting to speculate that the known gender differ-
nces in the risk of obesity-related cardiac dysfunction
ay have a causal relationship. To be certain, differ-
nces other than myocardial metabolism likely also
nfluence cardiac dysfunction development in obesity.
owever, our findings suggest that further study of
besity- and gender-related myocardial metabolic
hanges may yield novel, gender-specific therapeutic
argets for functional improvement.
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433ndependently modulate MBF and MVO2, and
lthough both modulate myocardial substrate me-
abolism, gender was a stronger predictor and af-
ected efficiency. Finally, it appears that the myo-
ardium can become insulin resistant with obesity,
nd gender and obesity interact in predicting myo-
ardial glucose uptake and insulin sensitivity.
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